Collaxio AB (COLLAX) Fair Value & Analysis
Financial Services · SE · Market cap 43.4M SEK
Fair value as of: Jul 20, 2026
From 2 valuation models · updated 21 days ago
Share price −11.8% over the past month.
Below-average quality, and screening another 46% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (kr 0.2975). The favourable scenario is already priced in.
- Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (kr 0.1615 to kr 0.2975) leaves room in how you read the outcome.
Price vs Fair Value (9 months)
White line = price, green steps = our fair value per fiscal year. As of Jul 20, 2026.
How to read this chart
9‑month range kr 0.4250 – kr 1.12 · fair‑value band kr 0.1615 – kr 0.2975 · the kr 0.4400 price screens above the kr 0.2380 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Jul 20, 2026.
Analysis
Collaxio AB (COLLAX) currently trades at kr 0.4400, while our model-based Fair Value estimate is kr 0.2380, implying the stock looks roughly 45.9% overvalued today. The Quality Score stands at 31/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
It earns a return on equity of -28.5%. Fundamentals as of Jul 20, 2026
Our scenario range runs from kr 0.1615 (bear case) to kr 0.2975 (bull case); at kr 0.4400, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 62% below its 52-week high, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -12% fair-value upside, at -46%, COLLAX screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: Multiples (kr 0.8700) versus Asset-Based (kr 0.6800). Highest evidence: P/B Multiple (55).
Notify me when COLLAX reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 38 · Market factors (momentum, volatility) 21
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Collaxio AB (publ) is a private equity, venture capital and secondary (direct) firm specializing in acquisitions & buy-and-build investments. It prefers to invest in four key sectors-B2B/SaaS & platform solutions, quality of life, transformational shifts and opportunistic.
Full company description
Collaxio AB (publ) is a private equity, venture capital and secondary (direct) firm specializing in acquisitions & buy-and-build investments. It prefers to invest in four key sectors-B2B/SaaS & platform solutions, quality of life, transformational shifts and opportunistic. It prefers to have a board representation and advisory board seats in its portfolio companies. Collaxio AB (publ) was founded in 2025 and is based in Stockholm, Sweden with additional offices in Shanghai, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Collaxio AB reported revenue of kr 944K in FY2025 versus −kr 23.0M in FY2022. Reported net income was −kr 35.4M in FY2025.
COLLAX screens 46% overvalued. Compare with Fondul Proprietatea SA →
Peer Group
Asset Management · 971 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Asset Management median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $0.0420 | $0.0800 | +90% |
| BlackRock, Inc BLK | $1,136 | $465.75 | -59% |
| Blackstone Inc BX | $124.56 | $16.35 | -87% |
| Investor AB INVEB | kr 423.70 | kr 847.40 | +100% |
| Brookfield Corporation BN | C$62.45 | C$10.12 | -84% |
| KKR & Co KKR | $100.94 | $44.88 | -56% |
| AB Industrivärden INDUA | kr 532.50 | kr 1,065 | +100% |
| Jio Financial Services Limited JIOFIN | ₹242.98 | ₹40.19 | -83% |
| Hedef Holding HEDEF | 267.25 TRY | 320.98 TRY | +20% |
| Bajaj Holdings BAJAJHLDNG | ₹10,398 | ₹9,202 | -12% |
Compare Collaxio AB with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Collaxio AB (COLLAX) overvalued or undervalued?
What is the fair value of COLLAX?
What is the quality score of COLLAX?
What is the net profit margin of COLLAX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Collaxio AB and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.